HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells.

Abstract
Andrographolide, the major bioactive component of Andrographis paniculata, has been demonstrated to have various biological properties including anti-inflammation, antioxidation, and anti-hepatotoxicity. Oxidative stress is considered a major risk factor in aging, inflammation, cancer, atherosclerosis, and diabetes mellitus. NADPH oxidase is a major source of endogenous reactive oxygen species (ROS). In this study, we used EA.hy926 endothelial-like cells to explore the anti-inflammatory activity of andrographolide. Andrographolide attenuated TNFα-induced ROS generation, Src phosphorylation, membrane translocation of the NADPH oxidase subunits p47(phox) and p67(phox), and ICAM-1 gene expression. In the small hairpin RNA interference assay, shp47(phox) abolished TNFα-induced p65 nuclear translocation, ICAM-1 gene expression, and adhesion of HL-60 cells. Andrographolide induced the gene expression of heme oxygenase 1 (HO-1) and glutamate cysteine ligase modifier subunit (GCLM) in a time-dependent manner. Cellular glutathione (GSH) content was increased by andrographolide. shGCLM attenuated the andrographolide-induced increase in GSH content and reversed the andrographolide inhibition of HL-60 adhesion. shHO-1 showed a similar effect on andrographolide inhibition of HL-60 adhesion to shGCLM. The mechanism underlying the up-regulation of HO-1 and GCLM by andrographolide was dependent on the PI3K/Akt pathway, and both the Nrf2 and AP-1 transcriptional factors were involved. Our results suggest that andrographolide attenuates TNFα-induced ICAM-1 expression at least partially through suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression, which is PI3K/Akt pathway-dependent.
AuthorsChia-Yang Lu, Ya-Chen Yang, Chien-Chun Li, Kai-Li Liu, Chong-Kuei Lii, Haw-Wen Chen
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 91 Issue 1 Pg. 40-50 (Sep 01 2014) ISSN: 1873-2968 [Electronic] England
PMID24998495 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014. Published by Elsevier Inc.
Chemical References
  • Diterpenes
  • NF-E2-Related Factor 2
  • NFE2L2 protein, human
  • Reactive Oxygen Species
  • Transcription Factor AP-1
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • andrographolide
  • HMOX1 protein, human
  • Heme Oxygenase-1
  • NADPH Oxidases
  • Proto-Oncogene Proteins c-akt
  • JNK Mitogen-Activated Protein Kinases
  • GCLM protein, human
  • Glutamate-Cysteine Ligase
  • Glutathione
Topics
  • Cell Adhesion (drug effects)
  • Cells, Cultured
  • Diterpenes (pharmacology)
  • Endothelial Cells (drug effects, metabolism)
  • Gene Expression Regulation (drug effects)
  • Glutamate-Cysteine Ligase (genetics, metabolism)
  • Glutathione (metabolism)
  • HL-60 Cells (drug effects)
  • Heme Oxygenase-1 (genetics, metabolism)
  • Humans
  • Intercellular Adhesion Molecule-1 (metabolism)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • NADPH Oxidases (metabolism)
  • NF-E2-Related Factor 2 (metabolism)
  • Oxidative Stress (drug effects)
  • Phosphatidylinositol 3-Kinases
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction (drug effects)
  • Transcription Factor AP-1 (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: